NCT04418388View on ClinicalTrials.gov

Pharmacokinetics and Safety of PBK-1801 After Single Oral Administration in Healthy Korean Women

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 24, 2019

Primary Completion Date

December 3, 2019

Study Completion Date

December 23, 2019

Conditions
Healthy Volunteer
Interventions
DRUG

PBK-1801

Administered orally

DRUG

PBK-1801

Administered orally

DRUG

PBK-1801

Administered orally

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Pharmbio Korea Co., Ltd.

INDUSTRY

NCT04418388 - Pharmacokinetics and Safety of PBK-1801 After Single Oral Administration in Healthy Korean Women | Biotech Hunter | Biotech Hunter